Solid-Phase Peptide Synthesis Explained: How Research Peptides Are Built One Residue at a Time
How solid-phase peptide synthesis works: resins, Fmoc and Boc protecting groups, coupling and deprotection cycles, cleavage, common impurities and purification.
Almost every synthetic peptide used in research today, from a five-residue fragment to a 40-residue analogue, is made by the same basic method: solid-phase peptide synthesis, or SPPS. Understanding how SPPS works helps explain why peptides carry the impurities they do, why purity is reported the way it is, and why some sequences are much harder to make than others. This guide walks through the chemistry in plain terms.
The problem SPPS solved
A peptide is a chain of amino acids joined by amide (peptide) bonds. Making that bond in a flask is easy. Making it in the right order, hundreds of times, without the wrong groups reacting, is not. Before the 1960s, peptides were assembled in solution, and after every single coupling step the growing chain had to be isolated and purified. A long peptide could take months.
In 1963, R. Bruce Merrifield published a different idea: anchor the first amino acid to an insoluble polymer bead, build the chain on that bead, and wash away excess reagents after each step by simple filtration. The growing peptide never leaves the solid support until the end. That paper, "Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide," changed the field, and Merrifield received the 1984 Nobel Prize in Chemistry for it.
The basic cycle
SPPS builds a peptide from the C-terminus to the N-terminus, which is the reverse of how a ribosome does it. Each added residue goes through the same repeating cycle:
- Deprotection. The amino group at the end of the resin-bound chain is protected by a temporary group. That group is removed to expose a free amine.
- Washing. Solvent washes remove the deprotection reagent and by-products.
- Activation and coupling. The next amino acid, with its own amino group protected, is activated at its carboxyl group with a coupling reagent and added in excess. It forms a new peptide bond with the exposed amine.
- Washing again. Excess amino acid and reagents are washed away.
The cycle repeats until the full sequence is assembled. Because reagents are used in excess and everything unbound is washed off, each step can be pushed close to completion, which is essential: small losses at every step compound over a long sequence.
Resins and linkers
The solid support is usually a cross-linked polystyrene or polyethylene glycol–based resin. Between the resin and the first amino acid sits a linker, a chemical handle that decides two things: how the finished peptide will be released, and what the C-terminus will look like. Some linkers release the peptide as a free acid; others give a C-terminal amide, which many native and research peptides carry.
Protecting groups: Boc and Fmoc
Amino acids have reactive groups beyond the backbone amine and carboxyl. Lysine has an extra amine, aspartic and glutamic acid have extra carboxyls, cysteine has a thiol, and so on. Every one of those side chains has to be blocked during synthesis, then unblocked at the end. The strategy relies on two classes of protection that come off under different conditions, often called orthogonal protection.
Boc chemistry. Merrifield's original approach used the tert-butyloxycarbonyl (Boc) group on the backbone amine, removed with moderate acid at each cycle. Side chains were protected with groups that only came off in very strong acid, historically hydrogen fluoride, at the final cleavage.
Fmoc chemistry. In 1970 and 1972, Louis Carpino and Grace Han introduced the 9-fluorenylmethoxycarbonyl (Fmoc) group, which is removed by a mild base such as piperidine. Paired with acid-labile side-chain groups, Fmoc lets the final cleavage use trifluoroacetic acid (TFA) instead of hydrogen fluoride. Fmoc SPPS is now the dominant method in research and commercial synthesis, largely because the conditions are milder and easier to automate. Reviews by Isidro-Llobet and colleagues (2009) and Behrendt and colleagues (2016) cover the large toolkit of protecting groups that has grown around it.
Cleavage and the crude peptide
When the chain is complete, a cleavage "cocktail," typically TFA with scavenger molecules, cuts the peptide from the linker and strips the side-chain protecting groups at the same time. Scavengers trap the reactive fragments released by deprotection so they don't re-attach to sensitive residues such as tryptophan, methionine or cysteine.
What comes out is the crude peptide: the target sequence mixed with everything that went slightly wrong along the way. The peptide is usually precipitated, collected and then purified.
Where impurities come from
SPPS impurities are predictable, and knowing them makes analytical data easier to read:
- Deletion sequences. If one coupling doesn't go to completion, some chains miss a residue. The result is a peptide one amino acid short, which can look very similar to the target.
- Truncated sequences. Chains that stop growing partway. Many protocols "cap" unreacted amines after each coupling so failures stay short and are easier to separate.
- Incomplete deprotection. A side-chain protecting group that survives cleavage adds a characteristic mass to the molecule.
- Side reactions. Aspartimide formation at aspartic acid, racemization (a residue flipping to its mirror-image form), and oxidation of methionine or cysteine are well-known examples.
- Counter-ions. Peptides cleaved and purified with TFA are usually isolated as TFA salts, so the powder contains counter-ion weight as well as peptide.
Long sequences and "difficult sequences," often hydrophobic stretches that aggregate on the resin, show more of these problems. That is why yields drop and purification gets harder as peptides get longer.
Purification and verification
Crude peptides are almost always purified by preparative reversed-phase HPLC, which separates molecules by hydrophobicity. Fractions containing the target are pooled and freeze-dried into the familiar lyophilized powder.
The final material is then checked by analytical HPLC (how much of the UV-absorbing material is the main peak) and mass spectrometry (whether the main peak has the expected molecular mass). Deletion sequences and protecting-group adducts are exactly the kinds of impurities those methods are designed to catch. Our guide to HPLC vs mass spectrometry explains what each result does and doesn't show, and the COA guide shows where those results appear on a certificate of analysis.
Modern refinements
SPPS today looks a lot like Merrifield's method, with decades of improvements: automated synthesizers, faster and cleaner coupling reagents, microwave-assisted and heated synthesis to push difficult couplings, pseudoproline and other building blocks that reduce aggregation, and native chemical ligation, which joins separately made peptide segments to reach small proteins. Stephen Kent's work on chemical protein synthesis showed how far the approach can be pushed.
Frequently asked questions
Why is SPPS done from the C-terminus to the N-terminus? The first residue is anchored to the resin through its carboxyl group, so the chain grows by adding new residues to the free amine at the other end.
What's the difference between Fmoc and Boc SPPS? Fmoc is removed with mild base and uses TFA for final cleavage. Boc is removed with acid at each step and traditionally needs much stronger acid at the end. Fmoc is the more common method today.
Why do longer peptides have lower purity? Every coupling step has a small failure rate, and those failures add up. Longer chains are also more likely to aggregate on the resin, which makes couplings less efficient.
What is a deletion sequence? A peptide missing one residue because a coupling step didn't complete. It is one of the most common SPPS impurities and is usually identified by mass spectrometry.
Related reading
- HPLC vs Mass Spectrometry: What Peptide Purity Testing Actually Shows
- Peptide COA Explained
- Endotoxin Testing for Research Peptides
All materials discussed are for laboratory research use only.
References
- Merrifield RB. Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide. Journal of the American Chemical Society. 1963;85(14):2149-2154. doi:10.1021/ja00897a025.
- Carpino LA, Han GY. 9-Fluorenylmethoxycarbonyl amino-protecting group. Journal of Organic Chemistry. 1972;37(22):3404-3409. doi:10.1021/jo00795a005.
- Isidro-Llobet A, Álvarez M, Albericio F. Amino acid-protecting groups. Chemical Reviews. 2009;109(6):2455-2504. doi:10.1021/cr800323s.
- Behrendt R, White P, Offer J. Advances in Fmoc solid-phase peptide synthesis. Journal of Peptide Science. 2016;22(1):4-27. doi:10.1002/psc.2836.
- The Nobel Prize in Chemistry 1984: Bruce Merrifield. NobelPrize.org.